Perfil
James A. Vollins worked as Secretary & Chief Compliance Officer at Bio Products Laboratory Ltd. from 2014 to 2018.
Then, served as Secretary & Chief Compliance Officer at BioDelivery Sciences International, Inc. from 2018 to 2022.
Most recently, held the position of Secretary & Chief Compliance Officer at Eiger BioPharmaceuticals, Inc. from 2023 to 2024.
Education includes undergraduate studies at Wesleyan University and graduate studies at Case Western Reserve University School of Law.
Antiguos cargos conocidos de James Vollins.
| Empresas | Cargo | Fin |
|---|---|---|
| EIGER BIOPHARMACEUTICALS | Oficial de Cumplimiento | 01/01/2024 |
| BIODELIVERY SCIENCES INTERNATIONAL, INC. | Oficial de Cumplimiento | 22/03/2022 |
Bio Products Laboratory Ltd.
Bio Products Laboratory Ltd. Pharmaceuticals: MajorHealth Technology Produces human blood plasma products to treat neurological & immunodeficiency and coagulation diseases | Oficial de Cumplimiento | 01/10/2018 |
Formación de James Vollins.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 5 |
|---|---|
BioDelivery Sciences International, Inc.
BioDelivery Sciences International, Inc. Pharmaceuticals: MajorHealth Technology Operates as a commercial stage pharmaceutical company to patients living with chronic pain | Health Technology |
Wesleyan University
Wesleyan University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Bio Products Laboratory Ltd.
Bio Products Laboratory Ltd. Pharmaceuticals: MajorHealth Technology Produces human blood plasma products to treat neurological & immunodeficiency and coagulation diseases | Health Technology |
Case Western Reserve University School of Law
Case Western Reserve University School of Law Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Eiger BioPharmaceuticals, Inc.
Eiger BioPharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies to treat and cure hepatitis delta virus and other serious diseases | Health Technology |
- Bolsa de valores
- Insiders
- James Vollins
















